C. Chou to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications C. Chou has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.373
-
Small molecules targeting histone H4 as potential therapeutics for chronic myelogenous leukemia. Mol Cancer Ther. 2008 Apr; 7(4):769-78.
Score: 0.296
-
Growth arrest of BCR-ABL positive cells with a sequence-specific polyamide-chlorambucil conjugate. PLoS One. 2008; 3(10):e3593.
Score: 0.077